W

FDA advisers vote against sleep peptide as they debate safety and health claims

Finance
Share
FDA advisers vote against sleep peptide as they debate safety and health claims

The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.

FDA advisers vote against sleep peptide as they debate safety and health claims

Source：MarketWatch

Disclaimer：Please read market information rationally and stay aware of investment risks. All content on this site is for informational purposes only and does not constitute investment advice.

Related Reading

Nvidia may face a more hostile post-election Washington: Report

CEO Jensen Huang’s relationship with President Donald Trump probably won’t save the company from a more adversarial Washington, Semafor says.…

Elon Musk opens the door for a big SpaceX acquisition

The rocket and satelliteinternet company is looking to challenge telecom giants. Source：MarketWatch

Data centers run on debt. That was a problem for bonds this year — and it’s only going to get worse.

AI debt issuance this year overwhelmed investor portfolios, and has disappointed from a performance perspective. The funding need won’t get any better with…

US Treasury cuts off MEXC over alleged $16B in illicit transactions

The US Treasury bureau FinCEN on Friday ordered US financial institutions to stop processing transfers involving MEXC Global. Source：Cointelegraph

Source：https://www.marketwatch.com/story/fda-advisers-vote-against-sleep-peptide-as-they-debate-safety-and-health-claims-2bc85739